The International Bill of Rights enshrines a right to health, which includes a right to access essential medicines. This right frequently appears to conflict with the intellectual property regime that governs pharmaceutical patents. However, there is also a human right that protects creative works, including scientific productions. Does this right support intellectual property protections, even when they may negatively affect health? This article examines the recent attempt by the Committee on Economic, Social and Cultural Rights to resolve this issue and argues that it fails. This is problematic because it means defenders of the present patent regime can continue using human rights documents to support their position. I offer a new framework for resolving the problem by examining the values that underlie human rights.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Read the full text or download the PDF:
Other content recommended for you
- Decolonising human rights: how intellectual property laws result in unequal access to the COVID-19 vaccine
- Human rights-based approach to tobacco control
- Assessment of short reports using a human rights-based approach to tobacco control to the Commitee on Economics, Cultural and Social Rights
- Will international human rights subsume medical ethics? Intersections in the UNESCO Universal Bioethics Declaration
- Human-tissue-related inventions: ownership and intellectual property rights in international collaborative research in developing countries
- The human rights responsibilities of multinational tobacco companies
- Intellectual property rights and detached human body parts
- Health and human rights are inextricably linked in the COVID-19 response
- Health professionals and human rights campaigners: different cultures, shared goals
- The COVID-19 vaccine patent: a right without rationale